Idea
Automated OCT segmentation tool delivering precise retinal atrophy and photoreceptor thickness metrics for effective AMD monitoring.
Research Paper
Core Innovation
This paper introduces a deep learning pipeline using three specialized semantic segmentation models to delineate RPE loss, EZ boundaries, and Bruch's membrane with high accuracy and reproducibility. It advances prior work by covering the full AMD phenotypic spectrum and validating on external datasets, ensuring robustness and clinical applicability.
Why It Matters
Accurate monitoring of geographic atrophy in AMD is critical for assessing disease progression and treatment response. This tool reduces manual effort and variability, improving clinical decision-making and enabling scalable, consistent patient monitoring in both trials and routine care.
Market Size (TAM)
$2–10B TAM for ophthalmic imaging AI; $500M–$1B SAM from AMD diagnostics and monitoring. Driven by aging populations and increasing AMD prevalence.
Potential Customers & Pain Points
- Ophthalmology clinics – Need reliable fast GA progression tracking
- Clinical trial sponsors – Require standardized reproducible biomarkers
- Medical imaging companies – Demand advanced segmentation tools
- Healthcare providers – Seek scalable AMD patient management solutions.
Business Model
SaaS platform licensing to ophthalmology clinics and imaging centers; partnerships with OCT device manufacturers for embedded AI; subscription-based clinical trial analytics services.
Competitive Landscape
- Topcon DRI OCT AI
- Zeiss Cirrus Advanced Analytics
- Heidelberg Spectralis AI
- Retina-AI Labs
Implementation Challenges
- Regulatory approval for clinical deployment
- Integration with diverse OCT hardware and workflows
- Clinician adoption and trust in automated metrics
Validation Strategy
- Conduct multi-center clinical validation studies
- Obtain regulatory clearances (FDA
- CE)
- Pilot deployments in ophthalmology clinics
- Collect real-world usage data to refine models
Research Paper Overview
Fully Automated High-Precision Segmentation of Retinal Atrophy and Ellipsoid Zone Thickness in OCT: A Reliable Tool for Real-World GA Monitoring
Summary
This paper presents a fully automated deep learning framework for precise pixel-wise segmentation of retinal pigment epithelium loss, ellipsoid zone loss, and thinning in OCT images to monitor geographic atrophy in AMD. Developed on a diverse dataset and validated externally, it achieves high accuracy and reproducibility, enabling reliable quantification of photoreceptor degeneration and RPE loss for clinical and real-world use.